13G Filing: Scopia Capital and GW Pharmaceuticals PLC- ADR (GWPH)

Page 6 of 12

Page 6 of 12 – SEC Filing

CUSIP No. 36197T103
Item 1. (a). Name of Issuer:
GW Pharmaceuticals PLC (the “Issuer”)
(b). Address of Issuer’s Principal Executive Offices:

Sovereign House, Vision Park

Chivers Way, Histon

Cambridge, CB24 9BZ

United Kingdom

Item 2. (a). Name of Person Filing:

Scopia Capital Management LP

Scopia Management, Inc.

Matthew Sirovich

Jeremy Mindich

(b). Address or Principal Business Office or, if None, Residence:

Scopia Capital Management LP

152 West 57th
Street, 33
rd Floor

New York, NY 10019

Scopia Management, Inc.

Matthew Sirovich

Jeremy Mindich

c/o Scopia Capital Management LP

152 West 57th
Street, 33
rd Floor

New York, NY 10019

(c). Citizenship:

Scopia Capital Management LP is a Delaware limited partnership

Scopia Management, Inc. is a New York corporation

Matthew Sirovich is a United States citizen

Jeremy Mindich is a United States citizen

(d). Title of Class of Securities:
American Depositary Shares, each representing 12 Ordinary Shares, par value £0.001 per share
(e). CUSIP Number:
36197T103
Item 3. If this statement is filed pursuant to §§.240.13d-1(b) or 240.13d-2(b), or (c), check whether the person filing is a:
(a) [_] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).

Follow Gw Pharmaceuticals Plc (NASDAQ:GWPH)

Page 6 of 12